Skip to main content
. 2020 Apr 9;52(10):2061–2068. doi: 10.1249/MSS.0000000000002364

TABLE 2.

Symptoms and health-related quality of life questionnaire scores (A) and PA triaxial accelerometry monitoring (B).

COPD CON P
A
 CAT 16 [6–29] 5 [0–18] 0.001
 mMRC 2 [0–4] 0 [0–1] 0.01
 SGRQ score
  Total 36 [11–73] 6 [0–48] 0.0002
  Active 48 [12–100] 12 [0–66] 0.0001
  Symptom 30 [0–56] 7 [0–48] 0.005
  Impacts 31 [0–80] 0 [0–39] 0.001
 SF-36 total score
   Mental component summary 46 [35–63] 51 [33–61] 0.405
   Physical component summary 39 [22–55] 55 [34–62] 0.0006
   Physical functioning scale 38 [19–55] 53 [28–57] 0.001
   Role-physical scale 37 [18–57] 57 [35–57] 0.0002
   Body pain scale 55 [37–62] 62 [33–61] 0.64
   General health scale 39 [26–53] 46 [38–63] 0.009
B
 Days of monitoring (n) 6.2 (±0.4) 6.0 (±0.0) 1.000
 Daytime VMU·min−1 (count) 300 (±170) 481 (±113) 0.042
 Steps per day (n) 4738 (±3194) 6372 (±2107) 0.286

A. Questionnaire scores are median [range min–max]. B. Data are mean (±SD). For SF-36, the mental and physical component summaries are aggregate scores. Bold font indicates significance at P < 0.05.